{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:31:23Z","timestamp":1792452683650,"version":"4.5.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,22]]},"DOI":"10.7759\/cureus.65136","type":"journal-article","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T22:42:15Z","timestamp":1721688135000},"source":"Crossref","is-referenced-by-count":9,"title":["Inflammatory Bowel Disease and Cardiovascular Disease: An Integrative Review With a Focus on the Gut Microbiome"],"prefix":"10.7759","author":[{"given":"Camila","family":"Sanchez Cruz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anahi","family":"Rojas Huerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Lima Barrientos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarfa","family":"Devani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Boosahda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naga S","family":"Rasagna Mareddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Briceno Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose C","family":"Del Castillo Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin A","family":"Reyes Gochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario D","family":"Reyes Gochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia E","family":"Ghattas Hasbun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(07)60751-x","article-title":"Inflammatory bowel disease: clinical aspects and established and evolving therapies","volume":"369","author":"Baumgart DC","year":"2007","unstructured":"Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet. 2007, 369:1641-57. 10.1016\/s0140-6736(07)60751-x","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-020-00639-y","article-title":"The risk of cardiovascular complications in inflammatory bowel disease","volume":"20","author":"Czubkowski P","year":"2020","unstructured":"Czubkowski P, Osiecki M, Szyma\u0144ska E, Kierku\u015b J. The risk of cardiovascular complications in inflammatory bowel disease. Clin Exp Med. 2020, 20:481-91. 10.1007\/s10238-020-00639-y","journal-title":"Clin Exp Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.63","article-title":"Inflammatory bowel disease is associated with an increased incidence of cardiovascular events","volume":"106","author":"Yarur AJ","year":"2011","unstructured":"Yarur AJ, Deshpande AR, Pechman DM, Tamariz L, Abreu MT, Sussman DA. Inflammatory bowel disease is associated with an increased incidence of cardiovascular events. Am J Gastroenterol. 2011, 106:741-7. 10.1038\/ajg.2011.63","journal-title":"Am J Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056944","article-title":"Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death-a Danish nationwide cohort study","volume":"8","author":"Kristensen SL","year":"2013","unstructured":"Kristensen SL, Ahlehoff O, Lindhardsen J, et al.. Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death-a Danish nationwide cohort study. PLoS One. 2013, 8:e56944. 10.1371\/journal.pone.0056944","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-020-00875-0","article-title":"Microbiome definition re-visited: old concepts and new challenges","volume":"8","author":"Berg G","year":"2020","unstructured":"Berg G, Rybakova D, Fischer D, et al.. Microbiome definition re-visited: old concepts and new challenges. Microbiome. 2020, 8:103. 10.1186\/s40168-020-00875-0","journal-title":"Microbiome"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9050977","article-title":"Systematic review: the gut microbiome and its potential clinical application in inflammatory bowel disease","volume":"9","author":"Aldars-Garc\u00eda L","year":"2021","unstructured":"Aldars-Garc\u00eda L, Chaparro M, Gisbert JP. Systematic review: the gut microbiome and its potential clinical application in inflammatory bowel disease. Microorganisms. 2021, 9:977. 10.3390\/microorganisms9050977","journal-title":"Microorganisms"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwad124","article-title":"Cardiovascular risk profiles in patients with inflammatory bowel disease differ from matched controls from the general population","volume":"30","author":"Sleutjes JA","year":"2023","unstructured":"Sleutjes JA, van der Woude CJ, Verploegh PJ, Aribas E, Kavousi M, Roeters van Lennep JE, de Vries AC. Cardiovascular risk profiles in patients with inflammatory bowel disease differ from matched controls from the general population. Eur J Prev Cardiol. 2023, 30:1615-22. 10.1093\/eurjpc\/zwad124","journal-title":"Eur J Prev Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae338","article-title":"Risk of heart failure in inflammatory bowel disease: a Swedish population-based study","author":"Sun J","year":"2024","unstructured":"Sun J, Yao J, Ol\u00e9n O, et al.. Risk of heart failure in inflammatory bowel disease: a Swedish population-based study. Eur Heart J. 2024, ehae338. 10.1093\/eurheartj\/ehae338","journal-title":"Eur Heart J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000032775","article-title":"Inflammatory bowel disease and associated cardiovascular disease outcomes: a systematic review","volume":"102","author":"Jaiswal V","year":"2023","unstructured":"Jaiswal V, Batra N, Dagar M, et al.. Inflammatory bowel disease and associated cardiovascular disease outcomes: a systematic review. Medicine (Baltimore). 2023, 102:e32775. 10.1097\/MD.0000000000032775","journal-title":"Medicine (Baltimore)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2023.07.003","article-title":"Incidence, prevalence, and racial and ethnic distribution of inflammatory bowel disease in the United States","volume":"165","author":"Lewis JD","year":"2023","unstructured":"Lewis JD, Parlett LE, Jonsson Funk ML, et al.. Incidence, prevalence, and racial and ethnic distribution of inflammatory bowel disease in the United States. Gastroenterology. 2023, 165:1197-205. 10.1053\/j.gastro.2023.07.003","journal-title":"Gastroenterology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v15.i11.553","article-title":"Cardiovascular implications of inflammatory bowel disease: an updated review","volume":"15","author":"Bhardwaj A","year":"2023","unstructured":"Bhardwaj A, Singh A, Midha V, Sood A, Wander GS, Mohan B, Batta A. Cardiovascular implications of inflammatory bowel disease: an updated review. World J Cardiol. 2023, 15:553-70. 10.4330\/wjc.v15.i11.553","journal-title":"World J Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.eii.2015.06.003","article-title":"Papel actual de los inmunomoduladores convencionales en la enfermedad inflamatoria intestinal pedi\u00e1trica","volume":"14","author":"Pujol Muncunill G","year":"2015","unstructured":"Pujol Muncunill G, Mart\u00edn de Carpi J. Papel actual de los inmunomoduladores convencionales en la enfermedad inflamatoria intestinal pedi\u00e1trica. Enferm Inflam Intest. 2015, 14:48-53. 10.1016\/j.eii.2015.06.003","journal-title":"Enferm Inflam Intest"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3012509","article-title":"Cardiovascular manifestations of inflammatory bowel disease: pathogenesis, diagnosis, and preventive strategies","volume":"2019","author":"Bunu DM","year":"2019","unstructured":"Bunu DM, Timofte CE, Ciocoiu M, Floria M, Tarniceriu CC, Barboi OB, Tanase DM. Cardiovascular manifestations of inflammatory bowel disease: pathogenesis, diagnosis, and preventive strategies. Gastroenterol Res Pract. 2019, 2019:3012509. 10.1155\/2019\/3012509","journal-title":"Gastroenterol Res Pract"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/ehjopen\/oeab029","article-title":"Inflammatory bowel disease and cardiovascular diseases: a concise review","volume":"2","author":"Wu H","year":"2022","unstructured":"Wu H, Hu T, Hao H, Hill MA, Xu C, Liu Z. Inflammatory bowel disease and cardiovascular diseases: a concise review. Eur Heart J Open. 2022, 2:oeab029. 10.1093\/ehjopen\/oeab029","journal-title":"Eur Heart J Open"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.55268","article-title":"Navigating the gut-cardiac axis: understanding cardiovascular complications in inflammatory bowel disease","volume":"16","author":"Sinha T","year":"2024","unstructured":"Sinha T, Zain Z, Bokhari SF, et al.. Navigating the gut-cardiac axis: understanding cardiovascular complications in inflammatory bowel disease. Cureus. 2024, 16:e55268. 10.7759\/cureus.55268","journal-title":"Cureus"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2020.03.003","article-title":"The gut microbiome and thromboembolism","volume":"189","author":"Hasan RA","year":"2020","unstructured":"Hasan RA, Koh AY, Zia A. The gut microbiome and thromboembolism. Thromb Res. 2020, 189:77-87. 10.1016\/j.thromres.2020.03.003","journal-title":"Thromb Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00499.2006","article-title":"Increased arginase activity and endothelial dysfunction in human inflammatory bowel disease","volume":"292","author":"Horowitz S","year":"2007","unstructured":"Horowitz S, Binion DG, Nelson VM, et al.. Increased arginase activity and endothelial dysfunction in human inflammatory bowel disease. Am J Physiol-Gastrointest Liver Physiol. 2007, 292:1323-36. 10.1152\/ajpgi.00499.2006","journal-title":"Am J Physiol-Gastrointest Liver Physiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht367","article-title":"Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis","volume":"35","author":"Kaptoge S","year":"2014","unstructured":"Kaptoge S, Seshasai SR, Gao P, et al.. Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis. Eur Heart J. 2014, 35:578-89. 10.1093\/eurheartj\/eht367","journal-title":"Eur Heart J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.5281\/ZENODO.8381548","article-title":"Transducci\u00f3n de Se\u00f1ales: De Lo Molecular a Lo Funcional, 1st ed","author":"Sampieri-Cabrera R","year":"2023","unstructured":"Sampieri-Cabrera R, Calder\u00f3n-Mart\u00ednez E. Transducci\u00f3n de Se\u00f1ales: De Lo Molecular a Lo Funcional, 1st ed. UNAM, Mexico; 2023. 10.5281\/ZENODO.8381548"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2174\/1871529X18666180103124443","article-title":"Exosomes in cholesterol metabolism and atherosclerosis","volume":"17","author":"Reiss AB","year":"2017","unstructured":"Reiss AB, Vernice NA, Siegart NM, De Leon J, Kasselman LJ. Exosomes in cholesterol metabolism and atherosclerosis. Cardiovasc Hematol Disord Drug Targets. 2017, 17:185-94. 10.2174\/1871529X18666180103124443","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.10.027","article-title":"Inflammatory bowel disease and atherosclerotic cardiovascular disease: JACC review topic of the week","volume":"76","author":"Cainzos-Achirica M","year":"2020","unstructured":"Cainzos-Achirica M, Glassner K, Zawahir HS, et al.. Inflammatory bowel disease and atherosclerotic cardiovascular disease: JACC review topic of the week. J Am Coll Cardiol. 2020, 76:2895-905. 10.1016\/j.jacc.2020.10.027","journal-title":"J Am Coll Cardiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/nature10208","article-title":"Intestinal homeostasis and its breakdown in inflammatory bowel disease","volume":"474","author":"Maloy KJ","year":"2011","unstructured":"Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature. 2011, 474:298-306. 10.1038\/nature10208","journal-title":"Nature"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-11-7","article-title":"High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease","volume":"11","author":"Walker AW","year":"2011","unstructured":"Walker AW, Sanderson JD, Churcher C, et al.. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol. 2011, 11:7. 10.1186\/1471-2180-11-7","journal-title":"BMC Microbiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/ismej.2007.52","article-title":"Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum","volume":"1","author":"Baumgart M","year":"2007","unstructured":"Baumgart M, Dogan B, Rishniw M, et al.. Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum. ISME J. 2007, 1:403-18. 10.1038\/ismej.2007.52","journal-title":"ISME J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00900-1","article-title":"The gut microbiome in atherosclerotic cardiovascular disease","volume":"8","author":"Jie Z","year":"2017","unstructured":"Jie Z, Xia H, Zhong SL, et al.. The gut microbiome in atherosclerotic cardiovascular disease. Nat Commun. 2017, 8:845. 10.1038\/s41467-017-00900-1","journal-title":"Nat Commun"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/apm.13038","article-title":"Gut microbiota in atherosclerosis: focus on trimethylamine N-oxide","volume":"128","author":"Zhu Y","year":"2020","unstructured":"Zhu Y, Li Q, Jiang H. Gut microbiota in atherosclerosis: focus on trimethylamine N-oxide. APMIS. 2020, 128:353-66. 10.1111\/apm.13038","journal-title":"APMIS"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.1897212","article-title":"The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health","volume":"13","author":"Nogal A","year":"2021","unstructured":"Nogal A, Valdes AM, Menni C. The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health. Gut Microbes. 2021, 13:1-24. 10.1080\/19490976.2021.1897212","journal-title":"Gut Microbes"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2246185","article-title":"Carbohydrate quality, fecal microbiota and cardiometabolic health in older adults: a cohort study","volume":"15","author":"Atzeni A","year":"2023","unstructured":"Atzeni A, Nishi SK, Babio N, et al.. Carbohydrate quality, fecal microbiota and cardiometabolic health in older adults: a cohort study. Gut Microbes. 2023, 15:2246185. 10.1080\/19490976.2023.2246185","journal-title":"Gut Microbes"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/jch.14722","article-title":"Gut microbiota changes in patients with hypertension: a systematic review and meta-analysis","volume":"25","author":"Cai M","year":"2023","unstructured":"Cai M, Lin L, Jiang F, Peng Y, Li S, Chen L, Lin Y. Gut microbiota changes in patients with hypertension: a systematic review and meta-analysis. J Clin Hypertens (Greenwich). 2023, 25:1053-68. 10.1111\/jch.14722","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-02045-6","article-title":"Roles of gut microbiota in atrial fibrillation: insights from Mendelian randomization analysis and genetic data from over 430,000 cohort study participants","volume":"22","author":"Dai H","year":"2023","unstructured":"Dai H, Hou T, Wang Q, et al.. Roles of gut microbiota in atrial fibrillation: insights from Mendelian randomization analysis and genetic data from over 430,000 cohort study participants. Cardiovasc Diabetol. 2023, 22:306. 10.1186\/s12933-023-02045-6","journal-title":"Cardiovasc Diabetol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/nqac074","article-title":"Gut microbiota-derived metabolite trimethylamine-N-oxide and multiple health outcomes: an umbrella review and updated meta-analysis","volume":"116","author":"Li D","year":"2022","unstructured":"Li D, Lu Y, Yuan S, et al.. Gut microbiota-derived metabolite trimethylamine-N-oxide and multiple health outcomes: an umbrella review and updated meta-analysis. Am J Clin Nutr. 2022, 116:230-43. 10.1093\/ajcn\/nqac074","journal-title":"Am J Clin Nutr"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.120.030643","article-title":"Gastrointestinal disorders and risk of first-ever ischemic stroke","volume":"51","author":"Roth WH","year":"2020","unstructured":"Roth WH, Cai A, Zhang C, Chen ML, Merkler AE, Kamel H. Gastrointestinal disorders and risk of first-ever ischemic stroke. Stroke. 2020, 51:3577-83. 10.1161\/STROKEAHA.120.030643","journal-title":"Stroke"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.15403\/jgld-4779","article-title":"The gut microbiota profile in heart failure patients: a systematic review","volume":"32","author":"Simadibrata DM","year":"2023","unstructured":"Simadibrata DM, Auliani S, Widyastuti PA, et al.. The gut microbiota profile in heart failure patients: a systematic review. J Gastrointest Liver Dis. 2023, 32:393-401. 10.15403\/jgld-4779","journal-title":"J Gastrointest Liver Dis"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1093\/nutrit\/nuae022","article-title":"Efficacy of probiotic supplementation and impact on fecal microbiota in patients with inflammatory bowel disease: a systematic review and meta-analysis of randomized controlled trials","author":"Xu M","year":"2024","unstructured":"Xu M, Zhang W, Lin B, et al.. Efficacy of probiotic supplementation and impact on fecal microbiota in patients with inflammatory bowel disease: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev. 2024, nuae022. 10.1093\/nutrit\/nuae022","journal-title":"Nutr Rev"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015084.pub2","article-title":"Prebiotics for induction and maintenance of remission in ulcerative colitis","volume":"3","author":"Sinopoulou V","year":"2024","unstructured":"Sinopoulou V, Gordon M, Gregory V, Saadeh A, Akobeng AK. Prebiotics for induction and maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev. 2024, 3:CD015084. 10.1002\/14651858.CD015084.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-023-05841-3","article-title":"A systematic review and meta-analysis of randomized clinical trials on the prevention and treatment of pouchitis after ileoanal pouch anastomosis","volume":"27","author":"Emile SH","year":"2023","unstructured":"Emile SH, Horesh N, Freund MR, et al.. A systematic review and meta-analysis of randomized clinical trials on the prevention and treatment of pouchitis after ileoanal pouch anastomosis. J Gastrointest Surg. 2023, 27:2650-60. 10.1007\/s11605-023-05841-3","journal-title":"J Gastrointest Surg"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13914","article-title":"Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease","volume":"32","author":"Facchin S","year":"2020","unstructured":"Facchin S, Vitulo N, Calgaro M, et al.. Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease. Neurogastroenterol Motil. 2020, 32:e13914. 10.1111\/nmo.13914","journal-title":"Neurogastroenterol Motil"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01399-2","article-title":"Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial","volume":"27","author":"Mocanu V","year":"2021","unstructured":"Mocanu V, Zhang Z, Deehan EC, et al.. Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial. Nat Med. 2021, 27:1272-9. 10.1038\/s41591-021-01399-2","journal-title":"Nat Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2295445","article-title":"Microbiota and mucosal gene expression of fecal microbiota transplantation or placebo treated patients with chronic pouchitis","volume":"16","author":"Hartikainen AK","year":"2024","unstructured":"Hartikainen AK, Khan I, Karjalainen EK, et al.. Microbiota and mucosal gene expression of fecal microbiota transplantation or placebo treated patients with chronic pouchitis. Gut Microbes. 2024, 16:2295445. 10.1080\/19490976.2023.2295445","journal-title":"Gut Microbes"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v16.i1.17","article-title":"Role of fecal microbiota transplant in management of hepatic encephalopathy: current trends and future directions","volume":"16","author":"Shah YR","year":"2024","unstructured":"Shah YR, Ali H, Tiwari A, et al.. Role of fecal microbiota transplant in management of hepatic encephalopathy: current trends and future directions. World J Hepatol. 2024, 16:17-32. 10.4254\/wjh.v16.i1.17","journal-title":"World J Hepatol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.121.036800","article-title":"Gut microbiota and their metabolites in stroke: a double-edged sword","volume":"53","author":"Peh A","year":"2022","unstructured":"Peh A, O'Donnell JA, Broughton BR, Marques FZ. Gut microbiota and their metabolites in stroke: a double-edged sword. Stroke. 2022, 53:1788-801. 10.1161\/STROKEAHA.121.036800","journal-title":"Stroke"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1111\/anec.13059","article-title":"Association of gut microbiome dysbiosis with the progression of atrial fibrillation: a systematic review","volume":"28","author":"Rashid S","year":"2023","unstructured":"Rashid S, Noor TA, Saeed H, et al.. Association of gut microbiome dysbiosis with the progression of atrial fibrillation: a systematic review. Ann Noninvasive Electrocardiol. 2023, 28:e13059. 10.1111\/anec.13059","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.008342","article-title":"Effect of vegan fecal microbiota transplantation on carnitine-and choline-derived trimethylamine-N-oxide production and vascular inflammation in patients with metabolic syndrome","volume":"7","author":"Smits LP","year":"2018","unstructured":"Smits LP, Kootte RS, Levin E, et al.. Effect of vegan fecal microbiota transplantation on carnitine-and choline-derived trimethylamine-N-oxide production and vascular inflammation in patients with metabolic syndrome. J Am Heart Assoc. 2018, 7:e008342. 10.1161\/JAHA.117.008342","journal-title":"J Am Heart Assoc"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000152","article-title":"ACG clinical guideline: ulcerative colitis in adults","volume":"114","author":"Rubin DT","year":"2019","unstructured":"Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG clinical guideline: ulcerative colitis in adults. Am J Gastroenterol. 2019, 114:384-413. 10.14309\/ajg.0000000000000152","journal-title":"Am J Gastroenterol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2018.27","article-title":"ACG clinical guideline: management of Crohn's disease in adults","volume":"113","author":"Lichtenstein GR","year":"2018","unstructured":"Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE. ACG clinical guideline: management of Crohn's disease in adults. Am J Gastroenterol. 2018, 113:481-517. 10.1038\/ajg.2018.27","journal-title":"Am J Gastroenterol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.19080\/OAJNN.2023.18.555979","article-title":"Neurological dysfunction associated with vitamin deficiencies: a narrative review","volume":"18","author":"Alejandra Nieto-Salazar M","year":"2023","unstructured":"Alejandra Nieto-Salazar M, Nicole Aguirre Ord\u00f3\u00f1ez K, Dorila Sosa Carcamo Z, et al.. Neurological dysfunction associated with vitamin deficiencies: a narrative review. Open Access J Neurol Neurosurg. 2023, 18:1-9. 10.19080\/OAJNN.2023.18.555979","journal-title":"Open Access J Neurol Neurosurg"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2015.120","article-title":"C-reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: a systematic review and meta-analysis","volume":"110","author":"Mosli MH","year":"2015","unstructured":"Mosli MH, Zou G, Garg SK, et al.. C-reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: a systematic review and meta-analysis. Am J Gastroenterol. 2015, 110:802-20. 10.1038\/ajg.2015.120","journal-title":"Am J Gastroenterol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.02.606","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk","volume":"63","author":"Andrus B","year":"2014","unstructured":"Andrus B, Lacaille D. 2013 ACC\/AHA guideline on the assessment of cardiovascular risk. J Am Coll Cardiol. 2014, 63:2886. 10.1016\/j.jacc.2014.02.606","journal-title":"J Am Coll Cardiol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy856","article-title":"'Ten commandments' for the fourth universal definition of myocardial infarction 2018","volume":"40","author":"Thygesen K","year":"2019","unstructured":"Thygesen K. 'Ten commandments' for the fourth universal definition of myocardial infarction 2018. Eur Heart J. 2019, 40:226. 10.1093\/eurheartj\/ehy856","journal-title":"Eur Heart J"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac051","article-title":"Corrigendum to: 2021 ESC\/EACTS guidelines for the management of valvular heart disease: developed by the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"43","author":"Vahanian A","year":"2022","unstructured":"Vahanian A. Corrigendum to: 2021 ESC\/EACTS guidelines for the management of valvular heart disease: developed by the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2022, 43:561. 10.1093\/eurheartj\/ehac051","journal-title":"Eur Heart J"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2568569","article-title":"Vascular endothelial dysfunction in inflammatory bowel diseases: pharmacological and nonpharmacological targets","volume":"2018","author":"Gravina AG","year":"2018","unstructured":"Gravina AG, Dallio M, Masarone M, et al.. Vascular endothelial dysfunction in inflammatory bowel diseases: pharmacological and nonpharmacological targets. Oxid Med Cell Longev. 2018, 2018:2568569. 10.1155\/2018\/2568569","journal-title":"Oxid Med Cell Longev"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jez219","article-title":"Imaging in ESC clinical guidelines: chronic coronary syndromes","volume":"20","author":"Saraste A","year":"2019","unstructured":"Saraste A, Barbato E, Capodanno D, et al.. Imaging in ESC clinical guidelines: chronic coronary syndromes. Eur Heart J Cardiovasc Imaging. 2019, 20:1187-97. 10.1093\/ehjci\/jez219","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv213","article-title":"The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease","volume":"10","author":"Harbord M","year":"2016","unstructured":"Harbord M, Annese V, Vavricka SR, et al.. The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease. J Crohns Colitis. 2016, 10:239-54. 10.1093\/ecco-jcc\/jjv213","journal-title":"J Crohns Colitis"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.5946\/ce.2016.090","article-title":"Endoscopic diagnosis and differentiation of inflammatory bowel disease","volume":"49","author":"Lee JM","year":"2016","unstructured":"Lee JM, Lee KM. Endoscopic diagnosis and differentiation of inflammatory bowel disease. Clin Endosc. 2016, 49:370-5. 10.5946\/ce.2016.090","journal-title":"Clin Endosc"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izaa156","article-title":"Disease activity in inflammatory bowel disease is associated with arterial vascular disease","volume":"27","author":"Card TR","year":"2021","unstructured":"Card TR, Zittan E, Nguyen GC, Grainge MJ. Disease activity in inflammatory bowel disease is associated with arterial vascular disease. Inflamm Bowel Dis. 2021, 27:629-38. 10.1093\/ibd\/izaa156","journal-title":"Inflamm Bowel Dis"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1102942","article-title":"Ulcerative colitis","volume":"365","author":"Danese S","year":"2011","unstructured":"Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med. 2011, 365:1713-25. 10.1056\/NEJMra1102942","journal-title":"N Engl J Med"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03613.x","article-title":"Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease","volume":"96","author":"Peeters M","year":"2001","unstructured":"Peeters M, Joossens S, Vermeire S, Vlietinck R, Bossuyt X, Rutgeerts P. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol. 2001, 96:730-4. 10.1111\/j.1572-0241.2001.03613.x","journal-title":"Am J Gastroenterol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i3.1304","article-title":"Antibody markers in the diagnosis of inflammatory bowel disease","volume":"22","author":"Mitsuyama K","year":"2016","unstructured":"Mitsuyama K, Niwa M, Takedatsu H, et al.. Antibody markers in the diagnosis of inflammatory bowel disease. World J Gastroenterol. 2016, 22:1304-10. 10.3748\/wjg.v22.i3.1304","journal-title":"World J Gastroenterol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.04.030","article-title":"Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease","volume":"131","author":"Dotan I","year":"2006","unstructured":"Dotan I, Fishman S, Dgani Y, et al.. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease. Gastroenterology. 2006, 131:366-78. 10.1053\/j.gastro.2006.04.030","journal-title":"Gastroenterology"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2015.1014407","article-title":"The epidemiology of inflammatory bowel disease","volume":"50","author":"Burisch J","year":"2015","unstructured":"Burisch J, Munkholm P. The epidemiology of inflammatory bowel disease. Scand J Gastroenterol. 2015, 50:942-51. 10.3109\/00365521.2015.1014407","journal-title":"Scand J Gastroenterol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2016.10.039","article-title":"Incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota from 1970 through 2010","volume":"15","author":"Shivashankar R","year":"2017","unstructured":"Shivashankar R, Tremaine WJ, Harmsen WS, Loftus EV Jr. Incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota from 1970 through 2010. Clin Gastroenterol Hepatol. 2017, 15:857-63. 10.1016\/j.cgh.2016.10.039","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.39436","article-title":"Aminotransferases in relation to the severity of dengue: a systematic review","volume":"15","author":"Kalluru PK","year":"2023","unstructured":"Kalluru PK, Mamilla M, Valisekka SS, et al.. Aminotransferases in relation to the severity of dengue: a systematic review. Cureus. 2023, 15:e39436. 10.7759\/cureus.39436","journal-title":"Cureus"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v15.i8.939","article-title":"Liver transplant in primary sclerosing cholangitis: current trends and future directions","volume":"15","author":"Shah YR","year":"2023","unstructured":"Shah YR, Nombera-Aznaran N, Guevara-Lazo D, et al.. Liver transplant in primary sclerosing cholangitis: current trends and future directions. World J Hepatol. 2023, 15:939-53. 10.4254\/wjh.v15.i8.939","journal-title":"World J Hepatol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1002\/jgh3.12831","article-title":"Inflammatory bowel disease type influences development of elevated liver enzymes","volume":"6","author":"Cheng YW","year":"2022","unstructured":"Cheng YW, McLean R, Sewell JL, Huang CY, Khalili M. Inflammatory bowel disease type influences development of elevated liver enzymes. JGH Open. 2022, 6:846-53. 10.1002\/jgh3.12831","journal-title":"JGH Open"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.3389\/FMED.2023.1320842\/BIBTEX","article-title":"Causal effects from inflammatory bowel disease on liver function and disease: a two-sample Mendelian randomization study","volume":"10","author":"Shu Y","year":"2023","unstructured":"Shu Y, Yang B, Liu X, Xu M, Deng C, Wu H. Causal effects from inflammatory bowel disease on liver function and disease: a two-sample Mendelian randomization study. Front Med (Lausanne). 2023, 10:1320842. 10.3389\/FMED.2023.1320842\/BIBTEX","journal-title":"Front Med (Lausanne)"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.47608","article-title":"Impact of silymarin supplements on liver enzyme levels: a systematic review","volume":"15","author":"Calderon Martinez E","year":"2023","unstructured":"Calderon Martinez E, Herrera D, Mogan S, et al.. Impact of silymarin supplements on liver enzyme levels: a systematic review. Cureus. 2023, 15:e47608. 10.7759\/cureus.47608","journal-title":"Cureus"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.3389\/FMED.2021.765474\/BIBTEX","article-title":"Treatment of inflammatory bowel disease: a comprehensive review","volume":"8","author":"Cai Z","year":"2021","unstructured":"Cai Z, Wang S, Li J. Treatment of inflammatory bowel disease: a comprehensive review. Front Med (Lausanne). 2021, 8:765474. 10.3389\/FMED.2021.765474\/BIBTEX","journal-title":"Front Med (Lausanne)"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v9.i2.321","article-title":"Gut microbiota and inflammatory bowel disease: the current status and perspectives","volume":"9","author":"Zheng L","year":"2021","unstructured":"Zheng L, Wen XL. Gut microbiota and inflammatory bowel disease: the current status and perspectives. World J Clin Cases. 2021, 9:321-33. 10.12998\/wjcc.v9.i2.321","journal-title":"World J Clin Cases"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.3390\/nu12030605","article-title":"The gut microbiota and its implication in the development of atherosclerosis and related cardiovascular diseases","volume":"12","author":"Sanchez-Rodriguez E","year":"2020","unstructured":"Sanchez-Rodriguez E, Egea-Zorrilla A, Plaza-D\u00edaz J, Arag\u00f3n-Vela J, Mu\u00f1oz-Quezada S, Tercedor-S\u00e1nchez L, Abadia-Molina F. The gut microbiota and its implication in the development of atherosclerosis and related cardiovascular diseases. Nutrients. 2020, 12:605. 10.3390\/nu12030605","journal-title":"Nutrients"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.122.19609","article-title":"Gut microbiota: friends or foes for blood pressure-lowering drugs","volume":"79","author":"Zheng T","year":"2022","unstructured":"Zheng T, Marques FZ. Gut microbiota: friends or foes for blood pressure-lowering drugs. Hypertension. 2022, 79:1602-4. 10.1161\/HYPERTENSIONAHA.122.19609","journal-title":"Hypertension"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000725","article-title":"Correction to: 2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"140","author":"Arnett DK","year":"2019","unstructured":"Arnett DK, Blumenthal RS, Albert MA, et al.. Correction to: 2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines. Circulation. 2019, 140:649-50. 10.1161\/CIR.0000000000000725","journal-title":"Circulation"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000001652","article-title":"Cardiovascular risk assessment in inflammatory bowel disease with coronary calcium score","volume":"86","author":"Chaudhry WA","year":"2024","unstructured":"Chaudhry WA, Ashfaq M, Kaur P, Kumar M, Faraz M, Malik J, Mehmoodi A. Cardiovascular risk assessment in inflammatory bowel disease with coronary calcium score. Ann Med Surg (Lond). 2024, 86:1496-505. 10.1097\/MS9.0000000000001652","journal-title":"Ann Med Surg (Lond)"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013854.pub2","article-title":"Patient education interventions for the management of inflammatory bowel disease","volume":"5","author":"Gordon M","year":"2023","unstructured":"Gordon M, Sinopoulou V, Ibrahim U, Abdulshafea M, Bracewell K, Akobeng AK. Patient education interventions for the management of inflammatory bowel disease. Cochrane Database Syst Rev. 2023, 5:CD013854. 10.1002\/14651858.CD013854.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20622","article-title":"What is the role of patient education in the care of IBD?","volume":"14","author":"Rakshit RC","year":"2008","unstructured":"Rakshit RC, Mayberry JF. What is the role of patient education in the care of IBD?. Inflamm Bowel Dis. 2008, 14:66-7. 10.1002\/ibd.20622","journal-title":"Inflamm Bowel Dis"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2022.08.012","article-title":"Inflammatory bowel disease and cardiovascular diseases","volume":"135","author":"Chen B","year":"2022","unstructured":"Chen B, Collen LV, Mowat C, et al.. Inflammatory bowel disease and cardiovascular diseases. Am J Med. 2022, 135:1453-60. 10.1016\/j.amjmed.2022.08.012","journal-title":"Am J Med"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11041016","article-title":"Fecal microbiota transplantation in inflammatory bowel disease","volume":"11","author":"Boicean A","year":"2023","unstructured":"Boicean A, Birlutiu V, Ichim C, Anderco P, Birsan S. Fecal microbiota transplantation in inflammatory bowel disease. Biomedicines. 2023, 11:1016. 10.3390\/biomedicines11041016","journal-title":"Biomedicines"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031886","article-title":"Sterile fecal microbiota transplantation boosts anti-inflammatory T-cell response in ulcerative colitis patients","volume":"25","author":"Chechushkov A","year":"2024","unstructured":"Chechushkov A, Desyukevich P, Yakovlev T, Al Allaf L, Shrainer E, Morozov V, Tikunova N. Sterile fecal microbiota transplantation boosts anti-inflammatory T-cell response in ulcerative colitis patients. Int J Mol Sci. 2024, 25:1886. 10.3390\/ijms25031886","journal-title":"Int J Mol Sci"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.864600","article-title":"Targeting trimethylamine N-oxide: a new therapeutic strategy for alleviating atherosclerosis","volume":"9","author":"Jing L","year":"2022","unstructured":"Jing L, Zhang H, Xiang Q, Shen L, Guo X, Zhai C, Hu H. Targeting trimethylamine N-oxide: a new therapeutic strategy for alleviating atherosclerosis. Front Cardiovasc Med. 2022, 9:864600. 10.3389\/fcvm.2022.864600","journal-title":"Front Cardiovasc Med"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.51422","article-title":"Ten steps to conduct a systematic review","volume":"15","author":"Calderon Martinez E","year":"2023","unstructured":"Calderon Martinez E, Flores Vald\u00e9s JR, Castillo JL, et al.. Ten steps to conduct a systematic review. Cureus. 2023, 15:e51422. 10.7759\/cureus.51422","journal-title":"Cureus"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-015-3797-3","article-title":"Trimethylamine-N-oxide: a novel biomarker for the identification of inflammatory bowel disease","volume":"60","author":"Wilson A","year":"2015","unstructured":"Wilson A, Teft WA, Morse BL, et al.. Trimethylamine-N-oxide: a novel biomarker for the identification of inflammatory bowel disease. Dig Dis Sci. 2015, 60:3620-30. 10.1007\/s10620-015-3797-3","journal-title":"Dig Dis Sci"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.5281\/ZENODO.8374707","article-title":"Correlatos Biopsicosociales En La Educaci\u00f3n M\u00e9dica Del Siglo XXI: De La Teor\u00eda a La Pr\u00e1ctica, 1st ed","author":"Sampieri-Cabrera R","year":"2023","unstructured":"Sampieri-Cabrera R, Calder\u00f3n-Mart\u00ednez E. Correlatos Biopsicosociales En La Educaci\u00f3n M\u00e9dica Del Siglo XXI: De La Teor\u00eda a La Pr\u00e1ctica, 1st ed. UNAM, Mexico; 2023. 10.5281\/ZENODO.8374707"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/273828-inflammatory-bowel-disease-and-cardiovascular-disease-an-integrative-review-with-a-focus-on-the-gut-microbiome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T22:42:21Z","timestamp":1721688141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/273828-inflammatory-bowel-disease-and-cardiovascular-disease-an-integrative-review-with-a-focus-on-the-gut-microbiome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,22]]},"references-count":81,"URL":"https:\/\/doi.org\/10.7759\/cureus.65136","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,22]]}}}